Detailed information for compound 1508193

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 476.399 | Formula: C23H27Cl2N5O2
  • H donors: 2 H acceptors: 2 LogP: 5.25 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C1N=C(N(C1=O)C(C)C)/N=C(\NC1C2CC3CC1CC(C2)C3)/Nc1ccc(c(c1)Cl)Cl
  • InChi: 1S/C23H27Cl2N5O2/c1-11(2)30-21(32)20(31)28-23(30)29-22(26-16-3-4-17(24)18(25)10-16)27-19-14-6-12-5-13(8-14)9-15(19)7-12/h3-4,10-15,19H,5-9H2,1-2H3,(H2,26,27,28,29,31)
  • InChiKey: FANKOGJGRYWUJR-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.00665706 0.325018 0.325018
Toxoplasma gondii DNA topoisomerase domain-containing protein 0.0190724 1 1
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.00665706 0.325018 1
Loa Loa (eye worm) hypothetical protein 0.00665706 0.325018 0.325018
Trypanosoma brucei hypothetical protein, conserved 0.00665706 0.325018 1
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.00665706 0.325018 0.311691
Leishmania major hypothetical protein, conserved 0.00665706 0.325018 1
Leishmania major hypothetical protein, conserved 0.00665706 0.325018 1
Echinococcus multilocularis Upstream activation factor subunit UAF30 0.0190724 1 1
Schistosoma mansoni hypothetical protein 0.0190724 1 1
Loa Loa (eye worm) SWIB/MDM2 domain-containing protein 0.0190724 1 1
Trypanosoma cruzi WLM domain containing protein, putative 0.00665706 0.325018 1
Loa Loa (eye worm) hypothetical protein 0.00665706 0.325018 0.325018
Leishmania major hypothetical protein, conserved 0.00665706 0.325018 1
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.00665706 0.325018 1
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0190724 1 1
Echinococcus granulosus Upstream activation factor subunit UAF30 0.0190724 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.00665706 0.325018 1
Toxoplasma gondii SWIB/MDM2 domain-containing protein 0.0190724 1 1
Trypanosoma brucei Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.00665706 0.325018 1
Leishmania major hypothetical protein, conserved 0.00665706 0.325018 1
Trypanosoma cruzi Zn-finger in Ran binding protein and others/FYVE zinc finger, putative 0.00665706 0.325018 1
Loa Loa (eye worm) CYP4Cod1 0.00103496 0.0193614 0.0193614
Trypanosoma cruzi mitochondrial RNA binding complex 1 subunit, putative 0.00665706 0.325018 1
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.00665706 0.325018 0.311691
Schistosoma mansoni hypothetical protein 0.0190724 1 1
Trypanosoma brucei mitochondrial RNA binding complex 1 subunit 0.00665706 0.325018 1
Plasmodium vivax SWIB/MDM2 domain-containing protein, putative 0.0190724 1 0.5
Echinococcus multilocularis SWI:SNF matrix associated 0.0190724 1 1
Chlamydia trachomatis SWIB complex protein 0.0190724 1 0.5
Loa Loa (eye worm) brahma associated protein 0.0190724 1 1
Chlamydia trachomatis DNA topoisomerase I 0.0190724 1 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.00665706 0.325018 1
Loa Loa (eye worm) hypothetical protein 0.00665706 0.325018 0.325018
Brugia malayi brahma associated protein 60 kDa 0.0190724 1 1
Brugia malayi SWIB/MDM2 domain containing protein 0.0190724 1 1
Schistosoma mansoni hypothetical protein 0.0190724 1 1
Brugia malayi brahma associated protein 60 kDa 0.0190724 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.00665706 0.325018 1
Schistosoma mansoni brg-1 associated factor 0.0190724 1 1
Echinococcus multilocularis SWI:SNF matrix associated 0.0190724 1 1
Plasmodium vivax hypothetical protein, conserved 0.0190724 1 0.5
Trypanosoma cruzi Zn-finger in Ran binding protein and others, putative 0.00665706 0.325018 1
Mycobacterium ulcerans cytochrome P450 185A4 Cyp185A4 0.00103496 0.0193614 0.5
Loa Loa (eye worm) cytochrome P450 family protein 0.00103496 0.0193614 0.0193614
Plasmodium falciparum SWIB/MDM2 domain-containing protein 0.0190724 1 1
Echinococcus granulosus SWI:SNF matrix associated 0.0190724 1 1
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.00665706 0.325018 0.311691
Echinococcus multilocularis SWI:SNF matrix associated 0.0190724 1 1
Loa Loa (eye worm) hypothetical protein 0.00665706 0.325018 0.325018
Trypanosoma cruzi WLM domain containing protein, putative 0.00665706 0.325018 1
Loa Loa (eye worm) cytochrome P450 family protein 0.00103496 0.0193614 0.0193614
Trypanosoma brucei hypothetical protein, conserved 0.00665706 0.325018 1
Leishmania major hypothetical protein, conserved 0.00665706 0.325018 1
Onchocerca volvulus 0.0190724 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0190724 1 0.5
Brugia malayi Zn-finger in Ran binding protein and others containing protein 0.00665706 0.325018 0.311691
Brugia malayi YY1-associated factor 2 0.00665706 0.325018 0.311691

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.81 ug ml-1 Antimicrobial activity against Plasmodium falciparum D6 by microdilution method ChEMBL. 21282058
IC50 (functional) = 2.07 ug ml-1 Antimicrobial activity against Plasmodium falciparum TM91C235 by microdilution method ChEMBL. 21282058
IC50 (functional) = 2.68 ug ml-1 Antimicrobial activity against Plasmodium falciparum W2 by microdilution method ChEMBL. 21282058
MED (functional) > 320 mg/kg/day Antiplasmodial activity against Plasmodium berghei sporozoites infected in orally dosed mouse administered for three consecutive days one day before infection ChEMBL. 21282058
MTD (ADMET) >= 320 mg/kg/day Toxicity in Plasmodium berghei sporozoites infected orally dosed mouse administered for three consecutive days one day before infection ChEMBL. 21282058

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23 21282058

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.